Rac-3-((5-(2-(5,6,7,8-Tetrahydro-1,8-naphthyridin-2-yl)ethoxy)pyridin-2-yl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic Acid

ID: ALA4518027

PubChem CID: 155541264

Max Phase: Preclinical

Molecular Formula: C25H25F3N4O3

Molecular Weight: 486.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC(Nc1ccc(OCCc2ccc3c(n2)NCCC3)cn1)c1ccc(C(F)(F)F)cc1

Standard InChI:  InChI=1S/C25H25F3N4O3/c26-25(27,28)18-6-3-16(4-7-18)21(14-23(33)34)32-22-10-9-20(15-30-22)35-13-11-19-8-5-17-2-1-12-29-24(17)31-19/h3-10,15,21H,1-2,11-14H2,(H,29,31)(H,30,32)(H,33,34)

Standard InChI Key:  FZYPHLOQWLUOKM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    4.4038  -19.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1202  -18.5889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1173  -17.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4020  -17.3493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890  -18.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6886  -17.7620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9758  -17.3509    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2588  -17.7627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2592  -18.5901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9766  -19.0057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8302  -17.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5462  -17.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2591  -17.3378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9752  -17.7477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9751  -18.5714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6902  -18.9812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4042  -18.5660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3984  -17.7368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6827  -17.3307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1208  -18.9749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8331  -18.5587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5496  -18.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2620  -18.5514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9785  -18.9602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2577  -17.7265    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8288  -17.7337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5428  -17.3198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5389  -16.4955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8219  -16.0859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1072  -16.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1146  -17.3293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8166  -15.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5283  -14.8438    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.0995  -14.8530    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.8123  -14.4330    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  3 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 21 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 29 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4518027

    ---

Associated Targets(Human)

ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 486.49Molecular Weight (Monoisotopic): 486.1879AlogP: 5.10#Rotatable Bonds: 9
Polar Surface Area: 96.37Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.97CX Basic pKa: 7.35CX LogP: 2.19CX LogD: 2.11
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: -0.75

References

1. Anderson NA, Campos S, Butler S, Copley RCB, Duncan I, Harrison S, Le J, Maghames R, Pastor-Garcia A, Pritchard JM, Rowedder JE, Smith CE, Thomas J, Vitulli G, Macdonald SJF..  (2019)  Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis.,  62  (19): [PMID:31497959] [10.1021/acs.jmedchem.9b00962]

Source